InvestorsHub Logo
Followers 0
Posts 41
Boards Moderated 0
Alias Born 04/03/2020

Re: None

Saturday, 04/04/2020 4:41:47 AM

Saturday, April 04, 2020 4:41:47 AM

Post# of 4873
"We are most hopeful about Gilead Sciences ’ (GILD) Remdesivir, which was developed to treat Ebola and Marburg. It is being adapted as a treatment for Covid. The in vitro data are promising; we should get more insight in four to six weeks."


https://www.barrons.com/articles/biotech-could-be-a-big-winner-in-a-post-pandemic-world-51585953254
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News